Plant sterol or stanol esters retard lesion formation in LDL receptor-deficient mice independent of changes in serum plant sterols

Journal of Lipid Research

Volumn 47, Issue 12, 2006, Pages 2762-2771

  Plat, Jogchum ^a   Beugels, Ilona ^a   Gijbels, Marion J J ^b,c   De Winther, Menno P J ^b   Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Atherosclerosis; Low density lipoprotein; Nutrition

Indexed keywords

ATORVASTATIN; LOW DENSITY LIPOPROTEIN RECEPTOR; STANOL ESTER; STEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIET SUPPLEMENTATION; DISEASE COURSE; DRUG EFFECT; FEMALE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL; CORONARY ARTERIOSCLEROSIS; FEMALE; HEPTANOIC ACIDS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHYTOSTEROLS; PYRROLES; RECEPTORS, LDL; SITOSTEROLS;

EID: 33845563662     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M600346-JLR200     Document Type: Article

References (34)

1. Katan, M. B., S. M. Grundy, P. Jones, M. Law, T. Miettinen, and R. Paoletti. 2003. Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels. Mayo Clin. Proc. 78: 965-978.
2. Grundy, S. M. 2001. United States Cholesterol Guidelines 2001: expanded scope of intensive low-density-lipoprotein-lowering therapy. Am. J. Cardiol. 88: 23j-27j.
3. Assman, G., P. Cullen, J. Erbey, D. R. Ramey, F. Kannenberg, and H. Schulte. 2006. Plasma sitosterol elevations are associated with an increased incidence of coronary events in men: results of a nested case control analysis of the Prospective Cardiovascular Munster (PROCAM) study. Nutr. Metab. Cardiovasc. Dis. 16: 13-21.
4. Lutjohann, D., and K. Von Bergmann. 1997. Phytosterolaemia: diagnosis, characterization and therapeutical approaches. Ann. Med. 29: 181-184.
5. Salen, G., I. Horak, M. Rothkopf, J. L. Cohen, J. Speck, G. S. Tint, V. Shore, B. Dayal, T. Chen, and S. Shefer. 1985. Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. J. Lipid Res. 26: 1126-1133.
6. Sudhop, T., B. M. Gottwald, and K. Von Bergmann. 2002. Serum plant sterols as a potential risk factor for coronary heart disease. Metabolism. 51: 1519-1521.
7. Miettinen, T. A., T. E. Strandberg, and H. Gylling. 2000. Noncholesterol sterols and cholesterol lowering by long-term simvastatin treatment in coronary patients: relation to basal serum cholestanol. Arterioscler. Thromb. Vasc. Biol. 20: 1340-1346.
8. Sutherland, W. H. F., M. J. A. Williams, E. R. Nye, N. J. Resticaux, S. A. de Jong, and H. L. Walker. 1998. Associations of plasma non-cholesterol sterol levels with severity of coronary artery disease. Nutr. Metab. Cardiovasc. Dis. 8: 386-391.
9. Willund, K. R., L. Yu, F. Xu, G. L. Vega, S. M. Grundy, J. C. Cohen, and H. H. Honns. 2004. No association between plasma levels of plant sterols and atherosclerosis in mice and men. Arterioscler. Thromb. Vasc. Biol. 24: 2326-2332.
10. Lanfer, K., M. Igel, T. Sudhop, and K. Von Bergmann. 2004. Elevated serum concentrations of plant sterols during treatment with atorvastatin decrease progressively during 1-year co-administration of ezetimibe. Abstract p126. Drugs Affecting Lipid Metabolism (DALM), Venice, October 24-27, 2004.
11. Miettinen, T. A., H. Gylling, N. Lindbohm, T. E. Miettinen, A. Radhakrishnan, A. Rajaratnam, and H. Relas. 2003. Serum noncholesterol sterols during inhibition of cholesterol synthesis by statins. J. Lab. Clin. Med. 141: 131-137.
12. Weststrate, J. A., and G. W. Meijer. 1998. Plant sterol-enriched margarines and reduction of plasma total and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 52: 334-343.
13. Naumann, E., J. Plat, and R. P. Mensink. 2003. Changes in serum concentrations of non-cholesterol sterols and lipoproteins in healthy subjects do not depend on the ratio of plant stanols in the diet. J. Nutr. 133: 2741-2747.
14. Ishibashi, S., M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenomediated gene delivery. J. Clin. Invest. 92: 883-893.
15. Plat, J., and R. P. Mensink. 2000. Vegetable oil based versus wood based stanol ester mixtures: effects on serum lipids and hemostatic factors in non hypercholesterolemic subjects. Atherosclerosis. 148: 101-112.
16. Ghesqueire, S. A., M. J. Gijbels, M. Anthonsen, P. J. van Gorp, I. van der Made, B. Johansen, M. H. Hofker, and M. P. de Winther. 2005. Macrophage-specific overexpression of group IIa Spla2 increases atherosclerosis and enhances collagen deposition. J. Lipid Res. 46: 201-210.
17. Kanters, E., M. Pasparakis, M. J. Gijbels, M. N. Vergouwe, J. Partouns-Hendriks, R. J. Fijneman, B. E. Clausen, I. Forster, M. M. Kockx, K. Rajewski, et al. 2003. Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. J. Clin. Invest. 112: 1176-1185.
18. van Vlijmen, B. J., A. M. van den Maagdenberg, M. J. Gijbels, H. van der Boom, H. HogenEsch, R. R. Frants, M. H. Hofker, and L. M. Havekes. 1994. Diet-induced hyperlipoproteinemia and atherosclerosis in apolipoprotein E3-Leiden transgenic mice. J. Clin. Invest. 93: 1403-1410.
19. Plat, J., and R. P. Mensink. 2001. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism. 50: 520-529.
20. Sehayek, E., and J. L. Breslow. 2005. Plasma plant sterol levels, another coronary heart disease risk factor? Arterioscler. Thromb. Vasc. Biol. 25: 5-6.
21. Connor, W. E., D. S. Lin, A. S. Pappu, J. Frohlich, and G. Gerhard. 2005. Dietary sitostanol and campestanol: accumulation in the blood of humans with sitosterolemia and xanthomatosis and in rat tissues. Lipids. 40: 919-923.
22. Teupser, D., A. D. Persky, and J. L. Breslow. 2003. Induction of atherosclerosis by low-fat semisynthetic diets in LDL receptor-deficient C57BL/6J and FVB/NJ mice: comparison of lesions of the aortic root, brachiocephalic artery, and whole aorta (en face measurement). Arterioscler. Thromb. Vasc. Biol. 23: 1907-1913.
23. Miettinen, T. A., and H. Gylling. 2003. Synthesis and absorption markers of cholesterol in serum and lipoproteins during a large dose of statin treatment. Eur. J. Clin. Invest. 33: 976-982.
24. Karha, J., and L. B. Deepack. 2005. Plaque regression - a new target for antiatherosclerotic therapy. Am. Heart J. 149: 384-387.
25. Petronio, A. S., G. Amoroso, U. Limbruno, B. Papini, M. DeCarlo, A. Micheli, N. Ciabatti, and M. Mariani. 2005. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am. Heart J. 149: 520-526.
26. Yonemura, A., Y. Momiyama, Z. A. Fayad, M. Ayaori, R. Ohmori, K. Higashi, T. Kihara, S. Sawada, N. Iwamoto, M. Ogura, et al. 2005. Effect of lipid-lowering therapy with atorvastatin on atherosclerotic aortic plaques detected by noninvasive magnetic resonance imaging. J. Am. Coll. Cardiol. 45: 733-742.
27. Nissen, S. E., T. Tsunoda, E. M. Tuzcu, P. Schoenhagen, C. J. Cooper, M. Yasin, G. M. Eaton, M. A. Lauer, W. S. Sheldon, C. L. Grines, et al. 2003. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. J. Am. Med. Assoc. 290: 2292-2300.
28. Moghadasian, M. H., D. V. Godin, B. M. McManus, and J. J. Frohlich. 1999. Lack of regression of atherosclerotic lesions in phytosterol-treated apo E-deficient mice. Life Sci. 64: 1029-1036.
29. Moghadasian, M. H., B. M. McManus, P. H. Pritchard, and J. J. Frohlich. 1997. "Tall oil"-derived phytosterols reduce atherosclerosis in apoE-deficient mice. Arterioscler. Thromb. Vasc. Biol. 17: 119-126.
30. Pritchard, P. H., M. Li, C. Zamfir, T. Lukic, E. Novak, and M. H. Moghadasian. 2003. Comparison of cholesterol-lowering efficacy and anti-atherogenic properties of hydrogenated versus non-hydrogenated (Phytrol) tall oil-derived phytosterols in apoE-deficient mice. Cardiovasc. Drugs Ther. 17: 443-449.
31. Moghadasian, M. H. 2006. Dietary phytosterols reduce cyclosporine induced hypercholesterolemia in apolipoprotein E-knockout mice. Transplantation. 81: 207-213.
32. Ratnayake, W. M. N.,M. R. L'Abbe, R. Mueller, S. Hayward, L. Plouffe, and R. Hollywood. 2000. Vegetable oils high in phytosterols make erythrocytes less deformable and shorten the life span of stroke-prone spontaneously hypertensive rats. J. Nutr. 130: 1166-1178.
33. de Jong, A., J. Plat, and R. P. Mensink. 2006. Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment. Eur. J. Clin. Nutr. 60: 985-990.
34. Yang, C., L. Yu, W. Li, F. Xu, J. C. Cohen, and H. H. Hobbs. 2004. Disruption of cholesterol homeostasis by plant sterols. J. Clin. Invest. 114: 813-822.